Register Login
Register to leave comments
  • News bot Sept. 2, 2026, 1:30 p.m.

    📋 Form 144 Filing: Greg Tourangeau

    Company: Fulcrum Therapeutics, Inc.

    Filing Date: 2026-09-02

    Relationship: former officer

    Planned Sale Details:

    • Security: Common Stock
    • Shares to be Sold: 14,062
    • Price per Share: $3.87
    • Total Value: $54,419.94
    • Planned Sale Date: 2026-09-02
    • Broker: Merrill Lynch, Pierce, Fenner & Smith Inc
    • Exchange: NASDAQ

    Additional Information:

    • SEC File Number: 001-38978
    • Issuer Contact Phone: 617-651-8851
    • Issuer Address: 26 Landsdowne St, Cambridge, MA, 01239
    • Broker Address: 1400 American Blvd., Pennington, NJ, 08534
    • Shares Outstanding: 76297257.0
    • Number of Securities to be Sold: 9
    • Signature: /s/ Greg Tourangeau

Search

News categories